40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-28.01%
Both companies show declining cash positions (-28.01% vs CRK's -95.18%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
No Data
No Data available this quarter, please select a different quarter.
-28.01%
Below half of CRK's -95.18%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
-34.82%
Higher Net Receivables Growth compared to CRK's zero value, indicating worse performance.
-84.84%
Higher Inventory Growth compared to CRK's zero value, indicating worse performance.
108.72%
Above 1.5x CRK's 35.39%. Michael Burry might investigate for potential short-term asset misclassification or risk.
-18.19%
Below half of CRK's 29.47%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
4.25%
≥ 1.5x CRK's 1.65%. David Dodd sees more aggressive capex. Confirm it's not overspending.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Higher Intangible Assets Growth compared to CRK's zero value, indicating worse performance.
-2.78%
Higher Goodwill + Intangibles Growth compared to CRK's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
28.20%
Less than half of CRK's -12.39%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
5.65%
≥ 1.5x CRK's 1.72%. David Dodd sees significantly higher long-term asset buildup. Confirm synergy with strategy.
-100.00%
Higher Other Assets Growth compared to CRK's zero value, indicating worse performance.
2.50%
0.75-0.9x CRK's 2.86%. Bill Ackman questions if competitor invests more aggressively for growth.
11.54%
Similar yoy growth to CRK's 15.36%. Walter Schloss sees parallel payables strategy. Check top-line correlation.
-66.63%
Higher Short-Term Debt Growth compared to CRK's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.23%
Similar yoy changes to CRK's -33.14%. Walter Schloss finds parallel near-term liability trends.
-10.25%
Above 1.5x CRK's -3.85%. Michael Burry sees a red flag for liquidity risk vs. competitor.
-18.42%
1.25-1.5x CRK's -13.83%. Martin Whitman is wary of bigger leverage expansion vs. competitor.
-100.00%
Both CRK and the company show zero Non-Current Deferred Revenue Growth.
14.72%
50-75% of CRK's 25.42%. Bruce Berkowitz notes relatively lower DTL growth.
0.34%
Less than half of CRK's -54.29%. David Dodd notes more conservative expansions in non-current obligations.
-5.89%
1.1-1.25x CRK's -4.84%. Bill Ackman questions if the firm is outpacing competitor in long-term leverage.
-100.00%
Higher Other Liabilities Growth compared to CRK's zero value, indicating worse performance.
-7.10%
Above 1.5x CRK's -4.68%. Michael Burry sees a potential leverage warning sign.
0.57%
Less than half of CRK's 1.70%. David Dodd sees fewer share issuances vs. competitor.
32.20%
1.25-1.5x CRK's 22.83%. Bruce Berkowitz notes stronger reinvestment strategy.
-10.21%
Above 1.5x CRK's -5.14%. Michael Burry sees a significant jump in intangible or market-based gains. Scrutinize risk of reversal.
-100.00%
Higher Other Stockholders' Equity Items Growth compared to CRK's zero value, indicating worse performance.
16.09%
≥ 1.5x CRK's 9.30%. David Dodd sees stronger capital base growth than competitor.
2.50%
0.75-0.9x CRK's 2.86%. Bill Ackman wonders if competitor invests or leverages more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-19.67%
1.25-1.5x CRK's -13.83%. Martin Whitman is wary of bigger debt expansions vs. competitor.
-19.52%
1.25-1.5x CRK's -13.29%. Martin Whitman is wary of heavier net leverage vs. competitor.
